Sweden Blood-based Biomaker For Sports Medicine Market Size & Outlook
Sweden blood-based biomaker for sports medicine market, 2018-2030 (US$M)
Related Markets
Sweden blood-based biomaker for sports medicine market highlights
- The Sweden blood-based biomaker for sports medicine market generated a revenue of USD 8.8 million in 2023 and is expected to reach USD 12.1 million by 2030.
- The Sweden market is expected to grow at a CAGR of 4.7% from 2024 to 2030.
- In terms of segment, ck was the largest revenue generating type in 2023.
- CRP is the most lucrative type segment registering the fastest growth during the forecast period.
Blood-based biomaker for sports medicine market data book summary
| Market revenue in 2023 | USD 8.8 million |
| Market revenue in 2030 | USD 12.1 million |
| Growth rate | 4.7% (CAGR from 2023 to 2030) |
| Largest segment | Ck |
| Fastest growing segment | CRP |
| Historical data | 2018 - 2022 |
| Base year | 2023 |
| Forecast period | 2024 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | CK, Myoglobin, Lactate, WBC, Urea, CRP, Lipid and Protein Hydroperoxides, IL-6 |
Other key industry trends
- In terms of revenue, Sweden accounted for 1.3% of the global blood-based biomaker for sports medicine market in 2023.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
- In Europe, Germany blood-based biomaker for sports medicine market is projected to lead the regional market in terms of revenue in 2030.
- Germany is the fastest growing regional market in Europe and is projected to reach USD 86.6 million by 2030.
Ck was the largest segment with a revenue share of 18.18% in 2023. Horizon Databook has segmented the Sweden blood-based biomaker for sports medicine market based on ck, myoglobin, lactate, wbc, urea, crp, lipid and protein hydroperoxides, il-6 covering the revenue growth of each sub-segment from 2018 to 2030.
In Sweden, the sports medicine market is evolving with an increased focus on advanced technologies, such as blood-based biomarkers. These biomarkers are crucial for monitoring athlete health, predicting injuries, and enhancing performance. The market for these diagnostic tools is expanding, driven by a growing interest in personalized sports medicine and advancements in medical technology.
Sports injuries, prevalent across various competition levels, often require comprehensive management and treatment. According to the “Swedish Olympic Athletes” report published by the NIH in July 2023, around 1,635 injuries were recorded among 468 athletes. The overall injury rate was 47.7 injuries per 100 athlete-years, equating to one injury per athlete approximately every 2 years. Gymnastics, tennis, and athletics had the highest injury rates.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Blood-based Biomaker for Sports Medicine Market Scope
Blood-based Biomaker for Sports Medicine Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
Sweden blood-based biomaker for sports medicine market size, by type, 2018-2030 (US$M)
Sweden Blood-based Biomaker for Sports Medicine Market Outlook Share, 2023 & 2030 (US$M)
Related industry reports
Related regional statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
